Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection

Biomaterials

Volumn 31, Issue 17, 2010, Pages 4771-4780

  Zeng, Xuan ^a   Sun, Yun Xia ^a   Qu, Wei ^a   Zhang, Xian Zheng ^a   Zhuo, Ren Xi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Biotin avidin system; Gene vector; Transferrin; Tumor target

Indexed keywords

ACID-BASE TITRATION; AGAROSE GEL ELECTROPHORESIS; APOPTOTIC; AVIDIN-BIOTIN; BIOCONJUGATES; BIOTIN-AVIDIN; CANCER CELLS; CELL LINES; CLINICAL APPLICATION; CONDENSED DNA; GEL ELECTROPHORESIS; GENE VECTOR; GENE VECTORS; HELA CELL; HUMAN CANCER; IN-VITRO; NORMAL FUNCTION; P53 GENE; P53 PROTEIN; POTENTIAL MEASUREMENTS; SEM; SPECIFIC INTERACTION; TARGETED GENE DELIVERY; TRANSFECTED CELLS; TRANSFERRIN; TUMOR CELLS; TUMOR SUPPRESSOR GENES; WESTERN BLOTTING;

ACIDS; BIOMOLECULES; CELL CULTURE; COENZYMES; COMPLEXATION; CONFOCAL MICROSCOPY; ELECTROPHORESIS; GELS; GENE TRANSFER; NUCLEIC ACIDS; TITRATION; TUMORS;

CELLS;

AVIDIN; DISULFIDE; POLYETHYLENEIMINE; PROTEIN P53; TRANSFERRIN;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOTINYLATION; CELL STRAIN COS7; CELL STRAIN HEPG2; CELL TYPE; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG SCREENING; GEL ELECTROPHORESIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TARGET CELL DESTRUCTION; ZETA POTENTIAL;

APOPTOSIS; AVIDIN; BIOTINYLATION; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DISULFIDES; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; IMINES; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; NEOPLASMS; POLYETHYLENES; TRANSFECTION; TRANSFERRIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77951093704     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.039     Document Type: Article

References (30)

1. Roth J.A., Swisher S.G., Meyn R.E. p53 tumor suppressor gene therapy for cancer. Oncology 1999, 13:148-154.
2. Lee J.M., Bernstein A. Apoptosis, cancer, and the p53 tumor suppressor gene. Cancer Metastasis Rev 1995, 14:149-161.
3. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007, 445:661-665.
4. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-4878.
5. O'Malley B.W., Couch M.E. Gene therapy principles and strategies for head and neck cancer. Adv Otorhinolaryngol 2000, 56:279-288.
6. Idogawa M., Sasaki Y., Suzuki H., Mita H., Imai K., Shinomura Y., et al. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Clin Cancer Res 2009, 15:3725-3732.
7. Roth J.A., Nguyen D., Lawrence D.D., Kemp B.L., Carrasco C.H., Ferson D.Z., et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 1996, 2:985-991.
8. Senatus P.B., Li Y., Mandigo C., Nichols G., Moise G., Mao Y., et al. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther 2006, 5:20-28.
9. Moffatt S., Wiehle S., Cristiano R.J. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene Ther 2006, 13:1512-1523.
10. Ndoye A., Merlin J.L., Leroux A., Dolivet G., Erbacher P., Behr J.P., et al. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes. J Gene Med 2004, 6:884-894.
11. Gautam A., Waldrep J.C., Kleinerman E.S., Xu B., Fung Y.K., T'Ang A., et al. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes. Methods Mol Med 2003, 75:607-618.
12. Li H., Qian Z.M. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002, 22:225-250.
13. Qian Z.M., Li H., Sun H., Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002, 54:561-587.
14. Hong M., Zhu S., Jiang Y., Tang G., Sun C., Fang C., et al. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. J Control Release 2010, 141:22-29.
15. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997, 4:409-418.
16. Liu Y., Tao J., Li Y., Yang J., Yu Y., Wang M., et al. Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Mol Ther 2009, 17:269-277.
17. Kircheis R., Wightman L., Schreiber A., Robitza B., Rössler V., Kursa M., et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001, 8:28-40.
18. DeLange R.J. Egg white avidin. I. Amino acid composition; sequence of the amino- and carboxyl-terminal cyanogen bromide peptides. J Biol Chem 1970, 245:907-916.
19. Laitinen O.H., Nordlund H.R., Hytonen V.P., Kulomaa M.S. Brave new (strept)avidins in biotechnology. Trends Biotechnol 2007, 25:269-277.
20. Huang H., Oizumi S., Kojima N., Niino T., Sakai Y. Avidin-biotin binding-based cell seeding and perfusion culture of liver-derived cells in a porous scaffold with a three-dimensional interconnected flow-channel network. Biomaterials 2007, 28:3815-3823.
21. Zeng X., Sun Y.X., Zhang X.Z., Cheng S.X., Zhuo R.X. A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates. Pharm Res 2009, 26:1931-1941.
22. Sun Y.X., Zeng X., Meng Q.F., Zhang X.Z., Cheng S.X., Zhuo R.X. The influence of RGD addition on the gene transfer characteristics of disulfide-containing polyethyleneimine/DNA complexes. Biomaterials 2008, 29:4356-4365.
23. Bajaj A., Kondaiah P., Bhattacharya S. Synthesis and gene transfection efficacies of PEI-Cholesterol-based lipopolymers. Bioconjugate Chem 2008, 19:1640-1651.
24. Doonan F., Cotter T.G. Morphological assessment of apoptosis. Methods 2008, 44:200-204.
25. Ziebarth J.D., Wang Y. Understanding the protonation behavior of linear polyethylenimine in solutions through Monte Carlo simulations. Biomacromolecules 2010, 11:29-38.
26. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J Controlled Release 1999, 60:149-160.
27. Rettig G.R., Rice K.G. Non-viral gene delivery: from the needle to the nucleus. Expert Opin Biol Ther 2007, 7:799-808.
28. Chung T.H., Wu S.H., Yao M., Lu C.W., Lin Y.S., Hung Y., et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007, 28:2959-2966.
29. Lee P.W., Hsu S.H., Tsai J.S., Chen F.R., Huang P.J., Ke C.J., et al. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 2010, 31:2425-2434.
30. Kurabayashi A., Furihata M., Matsumoto M., Ohtsuki Y., Sasaguri S., Ogoshi S. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia. Mod Pathol 2001, 14:741-747.